Linda M. Murphy

1.4k total citations
14 papers, 1.1k citations indexed

About

Linda M. Murphy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Linda M. Murphy has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Linda M. Murphy's work include Prostate Cancer Treatment and Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Molecular Biology Techniques and Applications (2 papers). Linda M. Murphy is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Molecular Biology Techniques and Applications (2 papers). Linda M. Murphy collaborates with scholars based in United States and Austria. Linda M. Murphy's co-authors include Lawrence J. Burgart, Thomas J. Sebo, Lewis R. Roberts, Ileana Aderca, José D. Debes, Donald J. Tindall, Patrick C. Roche, Ken Taniguchi, Jeremy C. Smith and Julie A. Ross and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer.

In The Last Decade

Linda M. Murphy

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linda M. Murphy United States	12	686	334	252	201	150	14	1.1k
Rajani Kanteti United States	21	761 1.1×	513 1.5×	446 1.8×	219 1.1×	183 1.2×	40	1.4k
Zizhen Feng China	12	671 1.0×	272 0.8×	140 0.6×	145 0.7×	73 0.5×	23	1.0k
Audrey Killian France	8	452 0.7×	599 1.8×	283 1.1×	155 0.8×	265 1.8×	9	1.0k
Analía Azaro Spain	18	569 0.8×	557 1.7×	295 1.2×	198 1.0×	121 0.8×	56	1.1k
Rajiv Bassi United States	19	925 1.3×	783 2.3×	373 1.5×	280 1.4×	108 0.7×	26	1.7k
Mónica Musteanu Spain	14	415 0.6×	552 1.7×	149 0.6×	181 0.9×	76 0.5×	32	972
Mark Gimbel United States	12	378 0.6×	680 2.0×	159 0.6×	155 0.8×	271 1.8×	17	1.0k
Paul R. Gavine China	15	928 1.4×	408 1.2×	407 1.6×	242 1.2×	118 0.8×	29	1.4k
Raija Ristamäki Finland	21	535 0.8×	760 2.3×	230 0.9×	307 1.5×	226 1.5×	52	1.3k
Da‐Liang Ou Taiwan	20	656 1.0×	508 1.5×	143 0.6×	320 1.6×	187 1.2×	53	1.3k

Countries citing papers authored by Linda M. Murphy

Since Specialization

Citations

This map shows the geographic impact of Linda M. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda M. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda M. Murphy more than expected).

Fields of papers citing papers by Linda M. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda M. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda M. Murphy. The network helps show where Linda M. Murphy may publish in the future.

Co-authorship network of co-authors of Linda M. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Linda M. Murphy. A scholar is included among the top collaborators of Linda M. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda M. Murphy. Linda M. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Adhikary, Sabina, Tanya L. Hoskin, Melody Stallings‐Mann, et al.. (2020). Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease. Breast Cancer Research and Treatment. 180(1). 55–61. 4 indexed citations

Degnim, Amy C., Tanya L. Hoskin, Marlene H. Frost, et al.. (2017). Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development. Clinical Cancer Research. 23(14). 3945–3952. 46 indexed citations

Shen, Jiayin, Yingwen Hu, Karson S. Putt, et al.. (2017). Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies. Oncotarget. 9(4). 4485–4495. 69 indexed citations

Visscher, Daniel W., Tanya L. Hoskin, Rushin D. Brahmbhatt, et al.. (2015). Abstract 2364: CD68+ immune cells show different infiltration patterns in tissue samples from women with no clinical breast disease and those who have benign breast disease. Cancer Research. 75(15_Supplement). 2364–2364. 1 indexed citations

Lai, Jin-Ping, Dalbir S. Sandhu, Chunrong Yu, et al.. (2010). Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors. Liver International. 30(10). 1522–1528. 26 indexed citations

Heemers, Hannelore V., Thomas J. Sebo, José D. Debes, et al.. (2007). Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells. Cancer Research. 67(7). 3422–3430. 82 indexed citations

Lai, Jinping, Chunrong Yu, Catherine D. Moser, et al.. (2006). SULF1 Inhibits Tumor Growth and Potentiates the Effects of Histone Deacetylase Inhibitors in Hepatocellular Carcinoma. Gastroenterology. 130(7). 2130–2144. 62 indexed citations

Sanderson, Schuyler O., Thomas J. Sebo, Linda M. Murphy, et al.. (2004). An Analysis of the p63/a-Methylacyl Coenzyme A Racemase Immunohistochemical Cocktail Stain in Prostate Needle Biopsy Specimens and Tissue Microarrays. American Journal of Clinical Pathology. 121(2). 220–225. 31 indexed citations

Burgart, Lawrence J., Michelle R. Mahoney, Harold E. Windschitl, et al.. (2004). Prognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer. Journal of Clinical Oncology. 22(9). 1572–1582. 108 indexed citations

10.

Sanderson, Schuyler O., Thomas J. Sebo, Linda M. Murphy, et al.. (2004). An Analysis of the p63/α-Methylacyl Coenzyme A Racemase Immunohistochemical Cocktail Stain in Prostate Needle Biopsy Specimens and Tissue Microarrays. American Journal of Clinical Pathology. 121(2). 220–225. 25 indexed citations

11.

Debes, José D., et al.. (2003). p300 in prostate cancer proliferation and progression.. PubMed. 63(22). 7638–40. 169 indexed citations

12.

Roche, Patrick C., Jan L. Kasperbauer, Daniel J. Sargent, et al.. (2003). Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer. 97(9). 2203–2211. 32 indexed citations

13.

Kakar, Sanjay, Trudie E. Muir, Linda M. Murphy, Ricardo V. Lloyd, & Lawrence J. Burgart. (2003). Immunoreactivity of Hep Par 1 in Hepatic and Extrahepatic Tumors and Its Correlation With Albumin In Situ Hybridization in Hepatocellular Carcinoma. American Journal of Clinical Pathology. 119(3). 361–366. 85 indexed citations

14.

Taniguchi, Ken, Lewis R. Roberts, Ileana Aderca, et al.. (2002). Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 21(31). 4863–4871. 378 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact